# Relapsed and/or Refractory Non-Hodgkin Lymphoma Study

> **NCT00837174** · PHASE2 · WITHDRAWN · sponsor: **The Methodist Hospital Research Institute**

## Conditions studied

- Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** Vorinostat in combination with Bortezomib

## Key facts

- **NCT ID:** NCT00837174
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-06
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never activated/opened as funding source and other support not available.
- **Last updated:** 2017-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837174, "Relapsed and/or Refractory Non-Hodgkin Lymphoma Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00837174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*